PCI Biotech Makes Headlines in Norway

Today – on The World Cancer Day – the Oslo Cancer Cluster member company PCI Biotech made the front page of the largest Norwegian Newspaper VG. “Norwegian Medical Sensation: Removes cancer with light – The tumours almost felt off” is the front page VG uses on describing PCI Biotechs result from their ongoing phase-I study at the University College of London (UCL).

Photo: PCI Biotech
Photo: PCI Biotech

Oslo – Powered by Nature

Oslo – Powered by Nature is a magazine published to help promoting Oslo as a top international region for business and knowledge.

Photo: Linda Cartridge/Oslo Cancer Cluster
Photo: Linda Cartridge/Oslo Cancer Cluster

Algeta strikes record deal with Bayer

Oslo-based cancer company Algeta has signed a USD 800 million global development and commercialization deal with Bayer, the German multinational pharma company, for its lead product candidate Alpharadin.This is probably the biggest deal made in Norwegian biotech industry in recent history.

Photo: Private
Photo: Private

New generation of bioentrepreneurs

Oncology research is growing strongly in Norway and Hanna Nemchenko is just one of the bright young researchers who has moved to Oslo. She is also among the first to enrol in special business-orientated courses promoted by Oslo Cancer Cluster and others to provide a new generation of bio-entrepreneurs. Originally from the Ukraine, she explains her course and shares impressions of the country.

Contact

Shortcut to Oslo Teknopol employees according to specialty

Your guide

Useful links arranged by subject

Newsletter

List of newsletters from Oslo Teknopol